Carregant...

A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of Immunity

Immunotherapy with chimeric antigen receptor T (CAR-T cells) has been recently approved for patients with relapsed/refractory B-lymphoproliferative neoplasms. Along with great efficacy in patients with poor prognosis, CAR-T cells have been also linked with novel toxicities in a significant portion o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Mol Sci
Autors principals: Gavriilaki, Eleni, Sakellari, Ioanna, Gavriilaki, Maria, Anagnostopoulos, Achilles
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7312228/
https://ncbi.nlm.nih.gov/pubmed/32485958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21113886
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!